• Alberto Espino, José Ignacio Vargas, Carla Mancilla, Pablo Muñoz, Waldo Martínez, Alejandra Menéndez, Daniela Jara, Rodrigo Mansilla, Giancarlo Schiappacasse, Mario Santamarina, Álvaro Huete, Roberto Candia, Felipe Silva, Cecilia Castillo, Hugo Richter, Ricardo Mejía, Paula Vial, Ignacio Robles, and Jorge Martínez.
• Departamento de Gastroenterología, Hospital Clínico UC-Christus, Pontificia Universidad Católica de Chile, Santiago, Chile.
• Rev Med Chil. 2021 Dec 1; 149 (12): 177317861773-1786.

AbstractPancreatic cystic neoplasms (PCN) are frequently detected on abdominal images performed for non-pancreatic indications. Their prevalence in asymptomatic population ranges from 2.7 to 24.8%, and increases with age. There are several types of pancreatic cysts. Some may contain cancer or have malignant potential, such as mucinous cystic neoplasms, including mucinous cystadenoma (MCN) and intraductal papillary mucinous neoplasms (IPMN). In contrast, others are benign, such as serous cystadenoma (SCA). However, even those cysts with malignant potential rarely progress to cancer. Currently, the only treatment for pancreatic cysts is surgery, which is associated with high morbidity and occasional mortality. The Board of the Chilean Pancreas Club of the Chilean Gastroenterology Society developed the first Chilean multidisciplinary consensus for diagnosis, management, and surveillance of PCN. Thirty experts were invited and answered 21 statements with five possible alternatives: 1) fully agree; 2) partially agree; 3) undecided; 4) disagree and 5) strongly disagree. A consensus was adopted when at least 80% of the sum of the answers "fully agree" and "partially agree" was reached. The consensus was approved by the Board of Directors of the Chilean Pancreas Club for publication.

12 keywords...

hide…